Viper venom for diabetic nephropathy

By Luiza Caramori, published in KI

font size decrease font size increase font size
Print
1 comment

Rate this item

(1 Vote)

Abstract:

Diabetic nephropathy is the leading cause of end-stage renal disease in the United States. Renin–angiotensin–aldosterone system (RAAS) blockers are thought to have a specific renoprotective effect in diabetes.

Hirst et al. report the results of randomized clinical trials assessing the effects of RAAS inhibitors on urinary albumin excretion levels in diabetic patients. Although reductions in urinary albumin excretion were observed, whether RAAS inhibitors offer additional protection over other antihypertensive agents is unclear.

This article is published in Kidney International: Kidney International (2012) 81, 615–616; doi:10.1038/ki.2011.460

Or, click here to read the full article...

Kidney International (2012) 81, 615–616; doi:10.1038/ki.2011.460

Additional Info

Language: English
Contains Audio: No
Content Type: Articles
Source: KI
Year: 2012
Members Only: No

Read 2525 times Last modified on Saturday, 22 March 2014 21:59

Published in Diabetes

Tagged under

Leave your comments

Post comment as a guest

Comments (1)

Guest - Dr. P.K.Sanyal
Permalink

Please make the full article available

about 4 years ago http://maps.google.com/maps?z=15&q=,

0 Like Share Short URL: Facebook Twitter Reply

Global Operations Center

Rue des Fabriques 1
1000 Brussels, Belgium
Tel: +32 2 808 04 20
Fax: +32 2 808 4454
Email contact

Americas Operations Center

340 North Avenue 3rd Floor
Cranford, NJ 07016-2496, United States
Tel: +1 567 248 9703
Fax: +1 908 272 7101
Email contact

Follow Us: